ArticleInternational journal of women's health2026
Primary HPV Infection in Postmenopausal Women: A Cohort Study to Enable Risk-Stratified Management.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aims both to identify the independent risk factors for high-grade cervical intraepithelial neoplasia (HSIL) and to develop and validate a clinical risk stratification model. Patients and Methods: This study retrospectively enrolled 400 postmenopausal women with HR-HPV high-risk human papillomavirus (HR-HPV) positivity and biopsy-confirmed cervical intraepithelial neoplasia. Univariate and multivariate logistic regression analyses were performed to identify independent predictors of HSIL, and a predictive model was constructed. This model was subsequently validated using an independent cohort of 172 patients. Results: Multivariate analysis identified older age, higher parity, HPV 16/18, and hypertension as independent risk factors for HSIL. The regression model based on these factors demonstrated good discrimination in the validation set, with an area under the receiver operating characteristic curve (AUC) of 0.805 in the training set and 0.778 in the validation set. Risk stratification according to the model revealed a significant ascending trend in HSIL prevalence across the defined risk groups. The diagnostic performance for HSIL was evaluated for key predictors, showing an AUC of 0.769 for HPV 16/18 genotype alone and 0.792 for its combination with age. Conclusion: A predictive model was constructed to effectively stratify the risk of HSIL in postmenopausal women with an initial HR-HPV infection. This tool facilitates the identification of high-risk individuals and provides a basis for individualized clinical management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.